Clinically proven

In a prospective clinical study of 123 patients at a leading US Hospital system using the MSIS-13 criteria as comparator, the Lyfstone Calprotectin test showed excellent sensitivity (98.1%) and specificity (95.7%). The calprotectin test outperformed blood-based PJI diagnostic tests such as CRP and ESR, confirming its diagnostic utility.

Source: Diagnostic Utility of a Novel Point-of-Care Test of Calprotectin for Periprosthetic Joint Infection after Total Knee Arthroplasty: A Prospective Cohort Study. https://clinicaltrials.gov/ct2/show/NCT03694925